The clinical research industry is unique among other industries for many reasons. Yet in the bigger picture, the way we interact with information has evolved, more or less, in step with the rest of the world. I can see parallels between changes in my own life and how clinical trials, and patient recruitment and engagement, have changed over the years.
In his last blog, our Patient Recruitment Global Alliance partner, Kevin Lin from Jsure, talked about the benefits of using Weibo, a Chinese social media network, for clinical trial patient recruitment. In this blog, he will explain how to prepare a Weibo strategy for patient recruitment in more detail.
In this series, we asked our Patient Recruitment Global Alliance partner, Kevin Lin from Jsure, to tell our readers more about patient recruitment in China. In part one, he explains how to use Weibo, one of the largest social networks, for clinical trial patient recruitment.
This is the second installment of our series showcasing our European Alliance partner, QuoMedic. To read the first interview responses, click here.
When conducting multinational patient recruitment campaigns, clinical trial sponsors need “on-the-ground” experts with first-hand knowledge of cultural acceptances in each of the study’s locations. Founded by BBK, the Patient Recruitment Global Alliance is comprised of vetted, trained, and experienced clinical trial communications and technology companies. The Alliance works across continents and time zones to meet the demands of today’s complex multinational enrollment challenges.
A friend will tell you a dress looks good, even if it doesn’t. A true friend would never do that. What’s more, a true friend accompanies you to the store, helps you pick out the right dress, and loans you the accessories you need for the occasion. This same sentiment can be true of global vendors and alliance partners. A vendor tells you they have the capabilities to complete the work you specifically outline, whereas an alliance partner will give you strategic consultation to ensure you are receiving the appropriate products and services for your campaign.
The clinical trial industry has grown into a multi-national, multi-protocol arena, and all players are forced to adapt. In BBK’s latest blog my colleague talks about the important factors needed to execute a successful multinational campaign, but this is only part of the solution. In order for a multinational campaign to truly be effective, the program materials must be adapted as well, ensuring that they have the desired effect in each participating county. As the cultural adaptation and translation processes can be complex and varied, I wanted to address some of the most common questions and misunderstandings that arise.
The other day, my colleague asked me the obvious question of, “How hard would it be to translate something into Japanese?” Easy question right? Wrong! The process of translating may seem straightforward but the amount of variables that need to be considered make this a process much more complex than most people realize. These variables appear throughout the life cycle of the materials beginning at their infancy in initial development through translation and adaptation and finally to effective implementation.